N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro

N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro is an N-Fmoc-protected amino acid derivative featuring an Fmoc carbamate on the α-amino position and a ω-amide or ω-amino functional handle bearing a 2,2,4,6,7-pentamethyldihydro substituent. The presence of a chiral, stereochemically defined amino acid backbone enables controlled peptide coupling while the bulky, highly substituted side-chain motif modulates sterics and conformational preferences during synthesis and downstream transformations. The Fmoc group provides orthogonal protection compatible with standard peptide synthesis workflows, while the ω-functional region can participate in further derivatization, including side-chain functionalization or conversion into additional peptide-like linkages. The compound's protected amine functionality and substituted aliphatic framework make it suitable as a research-grade intermediate for building stereodefined, side-chain-modified peptide analogs and for preparing chiral intermediates used in synthetic organic chemistry.

1. Peptide Synthesis

N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro is employed as an Fmoc-protected peptide building block in solid-phase and solution-phase peptide synthesis. The α-Fmoc carbamate enables base-labile deprotection to reveal a reactive α-amine for iterative amide bond formation, while the ω-substituted side-chain supports incorporation of sterically tuned residues into peptide sequences. The ω-functional handle can be leveraged for C-terminal or side-chain directed coupling strategies depending on the specific ω functionality present, supporting the construction of peptide analogs with controlled steric bulk. Downstream, the resulting protected peptide fragments can be carried into purification and fragment assembly steps to generate side-chain-modified peptides for biochemical research and structure-guided design.

2. Amino Acid Derivatization

N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro serves as a chiral amino acid derivative for side-chain functionalization and intermediate preparation in synthetic organic chemistry. The Fmoc-protected α-amine provides a stable handle during selective transformations of the ω-substituent, allowing chemists to introduce additional functional groups or convert the ω-region into coupling-ready motifs. The 2,2,4,6,7-pentamethyldihydro substituent can influence reactivity by imposing steric shielding and conformational constraints, which can be exploited when designing derivatives for controlled reactivity in subsequent steps. The protected amino acid framework supports orthogonal protection strategies that facilitate sequential derivatization, enabling downstream access to peptidomimetic scaffolds and non-natural amino acid analogs.

3. Peptidomimetics And SAR

N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro is applicable to peptidomimetic construction and structure-activity relationship studies requiring residues with defined steric and conformational character. The Fmoc-protected α-amine supports incorporation into peptide-like backbones, while the ω-substituted, highly methylated side-chain can be used to tune hydrophobic surface area, backbone folding propensity, and local steric environment. The resulting analogs can be generated as modular fragments for combinatorial assembly, enabling systematic variation of side-chain bulk while maintaining a consistent protected amino acid core for reliable synthesis. Downstream, these side-chain-modified peptide analogs can be used to prepare libraries of structure-defined compounds for SAR workflows and molecular design campaigns.

4. Chemical Manufacturing Intermediates

N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro can function as a process chemistry intermediate for manufacturing routes that require protected, stereochemically defined amino acid derivatives. The Fmoc group provides a commercially familiar protection strategy that can be introduced, stored, and removed under orthogonal conditions, supporting scalable synthesis of protected amino acid building blocks. The ω-substituent's substituted aliphatic structure is compatible with downstream conversion into additional coupling partners or functionalized intermediates used in fine chemical production. The compound's protected functional-group pattern supports stepwise manufacturing planning where controlled deprotection and subsequent derivatization are required to deliver consistent inputs for peptide synthesis and specialty chemical production.

5. Bioconjugation Platforms

N-α-Fmoc-N-ω-2,2,4,6,7-pentamethyldihydro is suitable for preparing bioconjugation-ready amino acid motifs used in chemical biology workflows. The protected α-amine allows controlled release of a reactive amine for incorporation into peptide linkers, while the ω-functional region can serve as a handle for further transformation into conjugation-compatible groups, such as coupling sites that can be introduced after Fmoc removal. The sterically defined pentamethyldihydro side-chain can influence linker conformation and accessibility, which may affect how conjugates present functional groups to biomolecular targets. Downstream, the synthesized peptide-like linkers and modified intermediates can be used to assemble labeled biomolecule constructs, enabling systematic studies of molecular recognition and conjugate architecture.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy